(Press-News.org) Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.
The recent study, published in the journal Nature Medicine, also offers a method to test new therapies in the lab and to better understand how tumours become resistant to drugs.
Small cell lung cancer (SCLC) is an aggressive disease with poor survival and new treatments are desperately needed. In many cases the tumour is inoperable and biopsies are difficult to obtain, giving scientists few samples with which to study the disease.
Now research carried out at Cancer Research UK's Manchester Institute, based at The University of Manchester – part of the Manchester Cancer Research Centre – has looked at the potential of using circulating tumour cells (CTCs) – cells that have broken off from the tumour and are circulating in the blood – to investigate a patient's disease in a minimally invasive manner.
The researchers, working closely with lung specialist and Medical Oncologist Dr Fiona Blackhall at The Christie NHS Foundation Trust, found that patients with SCLC had many more CTCs in a small sample of their blood than patients with other types of cancer. Importantly, the number of CTCs for each patient was related to their survival – patients with fewer CTCs in their blood lived longer.
Professor Caroline Dive, who led the study, said: "Access to sufficient tumour tissue is a major barrier to us fully understanding the biology of SCLC. This liquid biopsy is straightforward and not invasive so can be easily repeated and will allow us to study the genetics of each lung cancer patient's individual tumour. It also means that we may have a feasible way of monitoring patient response to therapy, hopefully allowing us to personalise and tailor individual treatment plans to each patient."
In addition, the team were able to use these CTCs to grow tumour models in mice, which they termed CTC-derived explants (CDXs). When they treated these mice with the same chemotherapy drugs as the SCLC patients they showed that the CDXs responded in the same way as each donor patient.
"We can use these models to help us understand why so many SCLC patients acquire resistance to chemotherapy and to search for and test potential new targeted treatments," added Professor Dive.
INFORMATION: END
'Liquid biopsy' offers new way to track lung cancer
2014-06-03
ELSE PRESS RELEASES FROM THIS DATE:
New insight into drug resistance in metastatic melanoma
2014-06-03
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.
Their findings suggest that using a combination of targeted therapies may be a more effective approach in the clinic.
Melanoma is a form of cancer that develops from melanocytes – the pigment-producing cells in skin. Advanced metastatic melanoma – where the cancer has spread throughout the body – is associated with poor survival, so new treatments are urgently needed.
In about 50% of melanoma cases, the tumour contains ...
Notifying speeding mariners lowers ship speeds in areas with North Atlantic right whales
2014-06-03
There are only around 500 North Atlantic right whales alive today. In an effort to further protect these critically endangered animals, a recent NOAA regulation required large vessels to reduce speed in areas seasonally occupied by the whales. The policy of notifying--but not necessarily citing--speeding vessels in protected areas was effective in lowering their speeds, helping to protect these magnificent creatures from ship collisions, while keeping punitive fines to mariners to a minimum.
A NOAA regulation, instituted in December 2008, requires vessels 65 feet or greater ...
Findings show benefit of changing measure of kidney disease progression
2014-06-03
Developing therapies for kidney disease can be made faster by adopting a new, more sensitive definition of kidney disease progression, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Renal Association-European Dialysis and Transplant Association Congress.
Chronic kidney disease (CKD) is a worldwide public health problem, with increasing prevalence, poor outcomes, and high treatment cost. Yet, despite the avail¬ability of simple laboratory tests to identify people with earlier stages of ...
Columbia Nursing study exposes infection risks in home health
2014-06-03
(NEW YORK, NY, June 3, 2014) – Millions of Americans depend on home health care services to recover from surgeries and hospital stays, as well as to manage daily life with chronic conditions. But all too often, evidence-based practices for preventing infections aren't followed when care is provided at home, leaving patients vulnerable to serious and potentially fatal complications. A study by researchers at Columbia University School of Nursing, published in the American Journal of Infection Control, found that unsterile living conditions and untrained caregivers contribute ...
Proteins 'ring like bells'
2014-06-03
As far back as 1948, Erwin Schrödinger—the inventor of modern quantum mechanics—published the book "What is life?"
In it, he suggested that quantum mechanics and coherent ringing might be at the basis of all biochemical reactions. At the time, this idea never found wide acceptance because it was generally assumed that vibrations in protein molecules would be too rapidly damped.
Now, scientists at the University of Glasgow have proven he was on the right track after all.
Using modern laser spectroscopy, the scientists have been able to measure the vibrational spectrum ...
Molecular 'scaffold' could hold key to new dementia treatments
2014-06-03
Researchers at King's College London have discovered how a molecular 'scaffold' which allows key parts of cells to interact, comes apart in dementia and motor neuron disease, revealing a potential new target for drug discovery.
The study, published today in Nature Communications, was funded by the UK Medical Research Council, Wellcome Trust, Alzheimer's Research UK and the Motor Neurone Disease Association.
Researchers looked at two components of cells: mitochondria, the cell 'power houses' which produce energy for the cell; and the endoplasmic reticulum (ER) which ...
Controlling thermal conductivities can improve energy storage
2014-06-03
Controlling the flow of heat through materials is important for many technologies. While materials with high and low thermal conductivities are available, materials with variable and reversible thermal conductivities are rare, and other than high pressure experiments, only small reversible modulations in thermal conductivities have been reported.
For the first time, researchers at the University of Illinois at Urbana-Champaign have experimentally shown that the thermal conductivity of lithium cobalt oxide (LixCoO2), an important material for electrochemical energy storage, ...
Tumor chromosomal translocations reproduced for the first time in human cells
2014-06-03
Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells, chromosomal translocations associated with two types of cancer: acute myeloid leukaemia and Ewing's sarcoma. The discovery, published today in the journal Nature Communications, opens the door to the development of new therapeutic targets to fight these types of cancer.
The study was carried out by Sandra Rodriguez-Perales − from CNIO's Molecular Cytogenetics Group, led ...
Children with autism have elevated levels of steroid hormones in the womb
2014-06-03
Scientists from the University of Cambridge and the Statens Serum Institute in Copenhagen, Denmark have discovered that children who later develop autism are exposed to elevated levels of steroid hormones (for example testosterone, progesterone and cortisol) in the womb. The finding may help explain why autism is more common in males than females, but should not be used to screen for the condition.
Funded by the Medical Research Council (MRC), the results are published today in the journal Molecular Psychiatry.
The team, led by Professor Simon Baron-Cohen and Dr ...
Reduced neurosurgical resident hours: No significant positive effect on patient outcomes
2014-06-03
Charlottesville, VA (June 3, 2014). In July 2003 the Accreditation Council for Graduate Medical Education (ACGME) imposed a mandatory maximum 80-hour work-week restriction on medical residents. Before that time residents often worked in excess of 100 hours per week. To investigate whether positive changes in patient outcomes occurred following implementation of the ACGME mandate, four researchers from Minnesota—Kiersten Norby, M.D., Farhan Siddiq, M.D., Malik M. Adil, M.D., and Stephen J. Haines, M.D.—analyzed hospital-based data from three years before (2000-2002) and ...